We are live on
!
Find out more
LP
Longview Partners Portfolio holdings
AUM
$7.06B
1-Year Est. Return
3.43%
This Fund
S&P 500
This Quarter
Est. Return
+5.96%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$19.1B
AUM Growth
+$587M
(+3.2%)
Cap. Flow
-$321M
Cap. Flow
% of AUM
-1.68%
Top 10 Holdings %
Top 10 Hldgs %
54.55%
Holding
25
New
–
Increased
21
Reduced
1
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$86.9M |
| 2 |
Willis Towers Watson
WTW
|
+$74M |
| 3 |
HCA Healthcare
HCA
|
+$71.3M |
| 4 |
Wells Fargo
WFC
|
+$62.3M |
| 5 |
Zimmer Biomet
ZBH
|
+$60.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$548M |
| 2 |
Progressive
PGR
|
+$296M |
| 3 |
Pediatrix Medical
MD
|
+$107M |
| 4 |
American Express
AXP
|
+$93.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.68% |
| 2 | Financials | 24.54% |
| 3 | Industrials | 19.86% |
| 4 | Technology | 14.95% |
| 5 | Consumer Staples | 5.56% |
Similar funds
NAMA
RPI
MNA
CWM
SC
OCA
DE
SBH
Longview Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Longview Partners held 25 positions worth $19.1B, up 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Longview Partners's Q4 2017 filing shows 21 increased, 1 reduced and 3 closed positions. The largest sale was Aptiv, an estimated $548M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Longview Partners added most to Oracle in Q4 2017, an estimated $86.9M increase.
- Longview Partners's biggest Q4 2017 reduction was Aptiv, cutting an estimated $548M.
- Longview Partners fully exited Progressive in Q4 2017, selling an estimated $296M.
- Longview Partners's ten largest holdings make up 55% of its $19.1B portfolio in Q4 2017.
- Longview Partners opened 0 new positions and closed 3 in Q4 2017.
- Longview Partners's portfolio value rose 3.2% quarter-over-quarter to $19.1B.
Based on Longview Partners's 13F filing for Q4 2017, filed 6 Feb 2018.